This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Igal Gery: Innovator in Uveitis Treatment
Introduction
Igal Gery is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of uveitis. His innovative work has led to the development of a unique pharmaceutical composition that utilizes suppressive oligonucleotides.
Latest Patents
Igal Gery holds 1 patent for his invention titled "Methods and compositions for the treatment of uveitis." This patent discloses pharmaceutical compositions that are effective in treating uveitis, including anterior, posterior, and diffuse forms of the condition. The compositions feature an immunosuppressive oligonucleotide, which plays a crucial role in the treatment process.
Career Highlights
Throughout his career, Igal Gery has worked with prominent organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and the University of Bristol. His work in these institutions has allowed him to advance his research and contribute to the medical community.
Collaborations
Igal Gery has collaborated with esteemed colleagues such as Dennis M Klinman and Chiaki Fujimoto. Their combined expertise has further enhanced the development of innovative treatments in the field of uveitis.
Conclusion
Igal Gery's contributions to the treatment of uveitis through his patented pharmaceutical compositions highlight his role as an influential inventor in the medical field. His work continues to pave the way for advancements in uveitis treatment.